TEST KIT, REVERSE BL

The contract specifies the procurement of a TEST KIT, REVERSE BLOOD GROUPING, AFFIRMAGEN, consisting of one 10 mL dropper top bottle of Group A1 cells and one 10 mL dropper top bottle of Group B cells, intended to confirm forward blood group testing. The item is identified by NSN 6550012045367 and manufacturer part number 719210 from ORTHO DIAGNOSTIC SYSTEMS INC, with a unit of issue set (SE) and a quantity of 2 units required. The product is regulated by the FDA and must be stored at a controlled temperature between 2 and 8 degrees Celsius without freezing, with a strict non-extendable shelf life of one month as a Type I (Code A) item. Packaging and marking must adhere strictly to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all packaging must be commercially sealed to protect contents from damage, with palletization and shipping containers conforming to DLA Packaging Requirements for Procurement (RP001). The material is not classified as hazardous under FED-STD-313 and must be commercially packaged per ASTM D3951, though DLA’s Master List of Technical and Quality Requirements takes precedence over any commercial standard. Delivery is required FOB destination within five days of award, with the final destination at the Naval Medical Readiness and Logistics Command in Williamsburg, VA. The product must be shipped by the fastest traceable means, avoiding parcel post. The solicitation number is SPE2DS-26-T-101A, with a response deadline of June 2, 2026, and the contract falls under NAICS code 621410 as a non-set-aside procurement. Contract administration requires electronic invoicing via WAWF, compliance with FAR and DFARS clauses covering cybersecurity, hazardous materials, whistleblower rights, trafficking in persons, ethical conduct, and the Buy American Act. All contractors must maintain current representations in SAM, validate their business size and socioeconomic status, and ensure compliance with DLA’s technical and quality requirements identified by R or I numbers. Inspection and acceptance occur at destination, and the contractor is solely responsible for personnel and property safety regardless of government actions.